The development of a 12-single nucleotide polymorphism (12-SNP) score has been found successful in differentiating healthy individuals from FH patients without one of the three common pathogenic variants (LDLR, ApoB, and PCSK9; Futema et al., 2015). This evidence concerns the gene PCSK9 and familial hyperaldosteronism.